QUADRANT CAPITAL GROUP LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 202 filers reported holding REPLIGEN CORP in Q2 2017. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$89,682
+79.6%
564
+59.8%
0.01%
+80.0%
Q2 2023$49,936
-59.1%
353
-51.3%
0.01%
-61.5%
Q1 2023$122,061
+21.6%
725
+22.3%
0.01%
+18.2%
Q4 2022$100,401
-25.6%
593
-17.5%
0.01%
-38.9%
Q3 2022$135,000
+121.3%
719
+92.8%
0.02%
+125.0%
Q2 2022$61,000
+60.5%
373
+88.4%
0.01%
+60.0%
Q1 2022$38,000
-28.3%
198
-1.0%
0.01%
-16.7%
Q4 2021$53,000
-15.9%
200
-8.7%
0.01%
-33.3%
Q3 2021$63,000
+103.2%
219
+39.5%
0.01%
+125.0%
Q2 2021$31,000
-18.4%
157
-19.1%
0.00%
-33.3%
Q1 2021$38,000
+31.0%
194
+26.8%
0.01%
+20.0%
Q4 2020$29,000
+31.8%
153
+4.1%
0.01%0.0%
Q3 2020$22,000
-12.0%
147
-27.6%
0.01%
-16.7%
Q2 2020$25,000
-79.3%
203
-83.9%
0.01%
-70.0%
Q1 2020$121,000
+7.1%
1,259
+1.5%
0.02%
+42.9%
Q4 2019$113,000
+21.5%
1,2410.0%0.01%0.0%
Q3 2019$93,000
-11.4%
1,2410.0%0.01%
-17.6%
Q2 2019$105,000
+5150.0%
1,241
+2926.8%
0.02%
Q1 2019$2,0000.0%410.0%0.00%
-100.0%
Q4 2018$2,0000.0%410.0%0.00%0.0%
Q3 2018$2,000
+100.0%
410.0%0.00%
Q2 2018$1,0000.0%410.0%0.00%
Q1 2018$1,0000.0%410.0%0.00%
Q4 2017$1,0000.0%410.0%0.00%
Q3 2017$1,000410.0%0.00%
Q2 2017$0
-100.0%
410.0%0.00%
Q1 2017$1,0000.0%410.0%0.00%
-100.0%
Q4 2016$1,0000.0%410.0%0.00%0.0%
Q3 2016$1,0000.0%410.0%0.00%0.0%
Q2 2016$1,0000.0%410.0%0.00%0.0%
Q1 2016$1,000410.00%
Other shareholders
REPLIGEN CORP shareholders Q2 2017
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders